Evidence map›Paper›PMID 25241892›Full record

ArticleOncogene2015

Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing.

J H Song, N An, S Chatterjee, E Kistner-Griffin, S Mahajan, S Mehrotra, A S Kraft

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J H Song1] Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA [2] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
N AnDepartment of Medicine, Medical University of South Carolina, Charleston, SC, USA.
S Chatterjee1] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA [2] Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
E Kistner-Griffin1] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA [2] Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
S MahajanHollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
S Mehrotra1] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA [2] Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
A S Kraft1] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA [2] Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT InhibitorsR01CA173200 · NCI · UNIVERSITY OF ARIZONA · PI KRAFT, ANDREW S · 2013 to 2017
$1.6M
NCI NIH HHS P30 CA138313NCI NIH HHS P30-CA138313NCI NIH HHS R01 CA173200NCI NIH HHS R01 CA1732000
6 · The paper itself

Abstract

The Pim protein kinases contribute to transformation by enhancing the activity of oncogenic Myc and Ras, which drives significant metabolic changes during tumorigenesis. In this report, we demonstrate that mouse embryo fibroblasts (MEFs) lacking all three isoforms of Pim protein kinases, triple knockout (TKO), cannot tolerate the expression of activated K-Ras (K-Ras(G12V)) and undergo cell death. Transduction of K-Ras(G12V) into these cells markedly increased the level of cellular reactive oxygen species (ROS). The addition of N-acetyl cysteine attenuated ROS production and reversed the cytotoxic effects of K-Ras(G12V) in the TKO MEFs. The altered cellular redox state caused by the loss of Pim occurred as a result of lower levels of metabolic intermediates in the glycolytic and pentose phosphate pathways as well as abnormal mitochondrial oxidative phosphorylation. TKO MEFs exhibit reduced levels of superoxide dismutase (Sod), glutathione peroxidase 4 (Gpx4) and peroxiredoxin 3 (Prdx3) that render them susceptible to killing by K-Ras(G12V)-mediated ROS production. In contrast, the transduction of c-Myc into TKO cells can overcome the lack of Pim protein kinases by regulating cellular metabolism and Sod2. In the absence of the Pim kinases, c-Myc transduction permitted K-Ras(G12V)-induced cell growth by decreasing Ras-induced cellular ROS levels. These results demonstrate that the Pim protein kinases have an important role in regulating cellular redox, metabolism and K-Ras-stimulated cell growth.

Indexed as

AnimalsCell ProliferationCells, CulturedFibroblastsGene Knockdown TechniquesHEK293 CellsHumansMiceMitochondriaPentose Phosphate PathwayProto-Oncogene Proteins c-pim-1Proto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesHras protein, mouseProto-Oncogene Proteins c-pim-1Proto-Oncogene Proteins p21(ras)proto-oncogene proteins pimReactive Oxygen Species

Identifiers

PMID25241892
PMCPMC4369476
OpenAlexW2010895681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.